Invention Grant
- Patent Title: Heteroarylacetamide inhibitors of factor Xa
- Patent Title (中): 因子Xa的杂芳基乙酰胺抑制剂
-
Application No.: US12025124Application Date: 2008-02-04
-
Publication No.: US07718659B2Publication Date: 2010-05-18
- Inventor: Markus Boehringer , Katrin Groebke Zbinden , Wolfgang Haap , Hans Hilpert , Narendra Panday , Fabienne Ricklin
- Applicant: Markus Boehringer , Katrin Groebke Zbinden , Wolfgang Haap , Hans Hilpert , Narendra Panday , Fabienne Ricklin
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Dennis P. Tramaloni; Brian C. Remy
- Priority: EP04106943 20041223
- Main IPC: A61K31/381
- IPC: A61K31/381 ; C07D417/12
Abstract:
The invention is concerned with novel heteroarylacetamides of formula (I) Rd—C(O)—N(Re)—Rc—CH2—C(O)—N(Ra)(Rb) (I) wherein Ra to Re are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
Public/Granted literature
- US20080146550A1 HETEROARYLACETAMIDE INHIBITORS OF FACTOR Xa Public/Granted day:2008-06-19
Information query
